Heart failure trials in Argentina

In Argentina 17 Also abroad 1265

17 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Where
Caba, CABA, Ciudad Autonoma de Buenos Aires, Córdoba, Morón, Ramos Meija, Rosario, San Miguel de Tucumán, San Nicolás de los Arroyos, Santa Fe, Villa María, Zárate
Age
18 years to 99 years
People
5,056 worldwide
Run by
Amgen
See details and how to joinNCT07037459
Phase 3Taking people
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Where
Bahía Blanca, Buenos Aire, Buenos Aires, Ciudad Autonoma Buenos Aires, Ciudad Autonoma de Bs As, Ciudad Autónoma de Bs As, Ciudadela, Córdoba, Coronel Suárez, Mar del Plata, Mendoza, Pilar, Quilmes, Ramos Mejía, Rosario, Salta, San Martin, San Miguel de Tucumán, San Nicolás, Santa Fe, Villa Luro
Age
18 years and over
People
6,712 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT06424288 · EU 2023-509706-30-00
Phase 3Taking people
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Where
Bahía Blanca, Buenos Aires, Ciudad Autonoma Buenos Aires, Córdoba, Coronel Suárez, Granadero Baigorria, Mar del Plata, Pilar, Quilmes, Ramos Mejía, Rosario, Salta, San Martin, San Miguel de Tucumán, San Nicolás, Santa Fe, Villa Luro
Age
18 years and over
People
4,200 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT06935370 · EU 2024-519525-38-00
Phase 3Taking people
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Where
Buenos Aires, Córdoba, La Plata, Rosario, Salta, Zárate
Age
Up to 18 years
People
117 worldwide
Run by
Bayer
See details and how to joinNCT07192952 · EU 2024-519830-22-00
Phase 2Taking people
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
Where
CABA, Córdoba, Ramos Mejía, Rosario, San Martin, Santa Fe
Age
18 years to 79 years
People
620 worldwide
Run by
Pfizer
See details and how to joinNCT06991257 · EU 2024-518438-94-00
Phase 3Taking people
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Where
Buenos Aires, CABA, Ciudad de Buenos Aires, Córdoba, La Plata, Mar del Plata, Rosario, San Nicolás, San Nicolás de los Arroyos, Santa Fe, San Vicente
Age
40 years and over
People
11,300 worldwide
Run by
AstraZeneca
See details and how to joinNCT06677060 · EU 2024-514506-32-00
Phase 3Taking people
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Where
Buenos Aires, Caba, Córdoba, Corrientes, Ramos Mejía, Santa Fe
Age
18 years and over
People
1,280 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07207811
Phase 3Taking people
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
Where
Buenos Aires, Ciudad Autonoma de Buenos Aire, Ciudad Autónoma de Buenos Aire, Córdoba, La Plata, Rosario, Salta, Zárate
Age
6 months to 17 years
People
111 worldwide
Run by
Bayer
See details and how to joinNCT07188805 · EU 2024-519829-38-00
Phase 3Taking people
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Where
Buenos Aires, CABA, Ciudad de Buenos Aires, Córdoba, Corrientes, Esperanza, Granadero Baigorria, Mar del Plata, Rosario, San Juan Bautista, San Miguel de Tucumán, Santa Fe
Age
18 years to 130 years
People
3,850 worldwide
Run by
AstraZeneca
See details and how to joinNCT06307652 · EU 2023-508162-15-00
Phase 3Taking people
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Where
Buenos Aires, CABA, Ciudad de Buenos Aires, Córdoba, Corrientes, Esperanza, Granadero Baigorria, Lanus, Mar del Plata, Mendoza, Rosario, San Nicolás, Santa Fe
Age
18 years and over
People
6,950 worldwide
Run by
AstraZeneca
See details and how to joinNCT07761117 · EU 2026-526304-79-00
Phase 3Taking people
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Where
Buenos Aires, Córdoba, Corrientes, Lanus, La Plata, Rafaela, Rosario, Salta, San Juan
Age
18 years and over
People
5,200 worldwide
Run by
Colorado Prevention Center
See details and how to joinNCT06008197
Phase 3Taking people
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Where
Buenos Aires, CABA, Capital Federal, City of Buenos Aires, Ciudad Autonoma de Buenos Aires, Córdoba, Esperanza, Santa Fe, Godoy Cruz, Mendoza, Lanús Este, La Plata, Buenos Aires, Pilar, Rosario, Salta, San Miguel de Tucumán, San Nicolás, Santa Fe, Santa Rosa, La Pampa
Age
18 years and over
People
5,610 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07567001 · EU 2025-523717-29-00
Phase 3Taking people
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
Where
Buenos Aires, Córdoba, Lanus, Rosario, San Juan
Age
18 years and over
People
2,600 worldwide
Run by
Colorado Prevention Center
See details and how to joinNCT06033950
Phase 4Taking people
Digoxin After Acute Heart Failure (DIG-DICA)
Where
Buenos Aires
Age
18 years to 120 years
People
120
Run by
Hospital General de Agudos "Dr. Cosme Argerich"
See details and how to joinNCT07321509
Phase 3Taking people
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
Where
Buenos Aires, CABA
Age
6 years to 11 years
People
60 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06597019
Phase 2Taking people
Cardiovascular Effects of SGLT2 Inhibitors in Hemodialysis Patients: A Phase 2 Randomized Study
Where
Buenos Aires
Age
18 years to 70 years
People
80
Run by
Maximo Agustin Schiavone
See details and how to joinNCT06929169
No phaseNot yet taking people in Argentina
Munich Transcatheter Mitral Valve Safety and Effectiveness
Where
Buenos Aires
Age
18 years and over
People
60 worldwide
Run by
P+F Products + Features GmbH
See details and how to joinNCT05871983